Literature DB >> 15283946

Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure.

Robin E Choo1, Marilyn A Huestis, Jennifer R Schroeder, Angela S Shin, Hendrée E Jones.   

Abstract

Maternal tobacco consumption during pregnancy has been associated with lower birth weight infants, preterm births, intrauterine growth retardation, smaller head circumference and increase in morbidity, yet few studies have examined the role tobacco has on the opiate neonatal abstinence syndrome (NAS). This study examined the effect of prenatal tobacco exposure on NAS for infants born to mothers maintained on methadone during gestation. Twenty-nine pregnant women and their newborn infants participated in this study. Tobacco exposure was based on maternal self-report with 16 women reporting cigarette consumption of 10 or less per day and 13 reporting smoking 20 cigarettes or more a day. The onset, peak, and duration of NAS were examined. Results showed that infants born to mothers who reported smoking 20 or more cigarettes per day had significantly higher NAS peak scores of 9.8 versus 4.8, and took longer to peak (113.0 h versus 37.8 h), than light smokers of 10 or fewer cigarettes per day. We concluded that tobacco use in conjunction with methadone plays an important role in the timing and severity of NAS in prenatally exposed infants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15283946     DOI: 10.1016/j.drugalcdep.2004.03.012

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  43 in total

Review 1.  Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review.

Authors:  Sarah C Akerman; Mary F Brunette; Alan I Green; Daisy J Goodman; Heather B Blunt; Sarah H Heil
Journal:  J Subst Abuse Treat       Date:  2014-12-22

2.  Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.

Authors:  Ursula A Pritham; Jonathan A Paul; Marie J Hayes
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2012-02-29

3.  Novel biomarkers to assess in utero effects of maternal opioid use: First steps toward understanding short- and long-term neurodevelopmental sequelae.

Authors:  Laura Goetzl; Tara Thompson-Felix; Nune Darbinian; Nana Merabova; Salim Merali; Carmen Merali; Kathryne Sanserino; Tamara Tatevosian; Bruno Fant; Mathieu E Wimmer
Journal:  Genes Brain Behav       Date:  2019-06-11       Impact factor: 3.449

4.  Tailoring a NICU-Based Tobacco Treatment Program for Mothers Who Are Dependent on Opioids.

Authors:  Amanda Fallin-Bennett; Kristin Ashford
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2017-07-26

Review 5.  Pharmacologic management of the opioid neonatal abstinence syndrome.

Authors:  Walter K Kraft; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-08-30       Impact factor: 3.278

6.  Maternal buprenorphine treatment and infant outcome.

Authors:  Lauren M Jansson; Martha L Velez; Krystle McConnell; Nancy Spencer; Michelle Tuten; Hendree Jones; Rebeca Rios; Van L King; Neeraj Gandotra; Lorraine Millio; Janet A DiPietro
Journal:  Drug Alcohol Depend       Date:  2017-08-31       Impact factor: 4.492

7.  Neonatal abstinence syndrome: Neurobehavior at 6 weeks of age in infants with or without pharmacological treatment for withdrawal.

Authors:  Nicole A Heller; Beth A Logan; Deborah G Morrison; Jonathan A Paul; Mark S Brown; Marie J Hayes
Journal:  Dev Psychobiol       Date:  2017-05-31       Impact factor: 3.038

8.  Should pregnant women with substance use disorders be managed differently?

Authors:  Verena Metz; Birgit Köchl; Gabriele Fischer
Journal:  Neuropsychiatry (London)       Date:  2012-01-25

9.  Illicit drug use among pregnant women enrolled in treatment for cigarette smoking cessation.

Authors:  Diann E Gaalema; Stephen T Higgins; Christopher S Pepin; Sarah H Heil; Ira M Bernstein
Journal:  Nicotine Tob Res       Date:  2012-10-15       Impact factor: 4.244

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.